Biocon recently presented data from its Insulin Tregopil clinical program at the American Diabetes Association’s (ADA) 78th Scientific Sessions held at Orlando, Florida, from 22nd to 26th June, 2018.
Professor Vivekanand Jha shares his views on how Dialysis is one of the first technological innovations in medicine and why we need to leverage this technology to address the huge kidney failure burden our country faces.
CEO Speaks: On the major milestone for Biocon-Sandoz and how this collaboration will enable Biocon to address the next wave of Global Biosimilar Opportunities!
Mr. Suresh Subramanian, Senior Vice President & Head Branded Formulations, Biocon shares his views on how KRABEVA® can make a significant impact in the biosimilars space.
Seema Ahuja, VP & Global Head of Communications, Biocon speaks on Healthcare PR, key challenges faced by the Healthcare and Pharma businesses & how in-house communication teams manage and navigate regulatory issues.
Diabetes & Diet FAQs: Geetha G H, dietitian, certified diabetes educator and sports nutritionist, answers your queries on how to fight diabetes with a balanced diet.
What kind of food can a person with diabetes eat and what kind of food should be avoided? How important is diet management in diabetes management? Find your answers here..
Biocon in its endeavour to fight diabetes is organising a webinar to create greater diabetes awareness and sensitize people with diabetes on life style modifications that could help them lead healthier and happier lives. Join us in 2 interactive webinars on November 23rd & November 28th, 2016 and help #BeatDiabetes! Eat Healthy! Live Healthy!!
Breast cancer is the second most common cancer in the world and, by far, the most frequent cancer among women. Every 19 seconds someone is diagnosed with breast cancer and every 74 seconds someone dies from it!
By Kiran Mazumdar Shaw Chairman & Managing Director, Biocon Limited.